NFAT activation by FKBP52 promotes cancer cell proliferation by suppressing p53

被引:0
|
作者
Hanaki, Shunsuke [1 ]
Habara, Makoto [1 ]
Tomiyasu, Haruki [1 ]
Sato, Yuki [1 ]
Miki, Yosei [1 ]
Masaki, Takahiro [1 ]
Shibutani, Shusaku [1 ,2 ]
Shimada, Midori [1 ,3 ]
机构
[1] Yamaguchi Univ, Dept Vet Biochem, Yamaguchi, Japan
[2] Yamaguchi Univ, Dept Vet Hyg, Yamaguchi, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Mol Biol, Nagoya, Japan
基金
日本学术振兴会;
关键词
HSP90-BINDING IMMUNOPHILIN FKBP52; GLUCOCORTICOID-RECEPTOR; ONCOPROTEIN MDM2; EXPRESSION; PROTEIN; MICROTUBULES; PROGRESSION; MODULATION; APOPTOSIS; TARGET;
D O I
10.26508/lsa.202302426
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
FK506-binding protein 52 (FKBP52) is a member of the FKBP family of proline isomerases. FKBP52 is up -regulated in various cancers and functions as a positive regulator of steroid hormone receptors. Depletion of FKBP52 is known to inhibit cell proliferation; however, the detailed mechanism remains poorly understood. In this study, we found that FKBP52 depletion decreased MDM2 transcription, leading to stabilization of p53, and suppressed cell proliferation. We identi fied NFATc1 and NFATc3 as transcription factors that regulate MDM2 . We also found that FKBP52 associated with NFATc3 and facilitated its nuclear translocation. In addition, calcineurin, a well-known Ca 2+ phosphatase essential for activation of NFAT, plays a role in MDM2 transcription. Supporting this notion, MDM2 expression was found to be regulated by intracellular Ca 2+ . Taken together, these findings reveal a new role of FKBP52 in promoting cell proliferation via the NFAT-MDM2-p53 axis, and indicate that inhibition of FKBP52 could be a new therapeutic tool to activate p53 and inhibit cell proliferation.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells
    Hu, Min
    Liu, Lisheng
    Yao, Weirong
    GENE, 2018, 678 : 261 - 269
  • [42] SMYD3 promotes epithelial ovarian cancer metastasis by downregulating p53 protein stability and promoting p53 ubiquitination
    Zhang, Liwei
    Jin, Yue
    Yang, Hao
    Li, Yu
    Wang, Chao
    Shi, Yongheng
    Wang, Yu
    CARCINOGENESIS, 2019, 40 (12) : 1492 - 1503
  • [43] Long non-coding RNA p53 upregulated regulator of p53 levels (PURPL) promotes the development of gastric cancer
    Cheng, Zhonghua
    Hong, Jing
    Tang, Nan
    Liu, Fenghua
    Gu, Shuo
    Feng, Zhen
    BIOENGINEERED, 2022, 13 (01) : 1359 - 1376
  • [44] TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway
    Chen, Liuyan
    Qing, Jilin
    Xiao, Yangyang
    Huang, Xiaomei
    Chi, Yanlin
    Chen, Zhizhong
    BMC CANCER, 2022, 22 (01)
  • [45] Evidence for activation of mutated p53 by apigenin in human pancreatic cancer
    King, Jonathan C.
    Lu, Qing Yi
    Li, Gang
    Moro, Aune
    Takahashi, Hiroki
    Chen, Monica
    Go, Vay Liang W.
    Reber, Howard A.
    Eibl, Guido
    Hines, O. Joe
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2012, 1823 (02): : 593 - 604
  • [46] DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways
    Du, Feng
    Sun, Lina
    Chu, Yi
    Li, Tingyu
    Lei, Chao
    Wang, Xin
    Jiang, Mingzuo
    Min, Yali
    Lu, Yuanyuan
    Zhao, Xiaodi
    Nie, Yongzhan
    Fan, Daiming
    CANCER COMMUNICATIONS, 2018, 38
  • [47] Quantitative comparison of apoptosis to cell proliferation and p53 protein in breast carcinomas
    Zheng, WQ
    Zhan, RZ
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1998, 20 (01): : 1 - 6
  • [48] Histone deacetylase 3 promotes pancreatic cancer cell proliferation, invasion and increases drug-resistance through histone modification of P27, P53 and Bax
    Jiao, Feng
    Hu, Hai
    Yuan, Cuncun
    Jin, Ziliang
    Guo, Zhen
    Wang, Liwei
    Wang, Lei
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (04) : 1523 - 1530
  • [49] AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53
    Kalous, Ondrej
    Conklin, Dylan
    Desai, Amrita J.
    Dering, Judy
    Goldstein, Jennifer
    Ginther, Charles
    Anderson, Lee
    Lu, Ming
    Kolarova, Teodora
    Eckardt, Mark A.
    Langerod, Anita
    Borresen-Dale, Anne-Lise
    Slamon, Dennis J.
    Finn, Richard S.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 141 (03) : 397 - 408
  • [50] NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer
    Liu, Rong-Zong
    Vo, The M.
    Jain, Saket
    Choi, Won-Shik
    Garcia, Elizabeth
    Monckton, Elizabeth A.
    Mackey, John R.
    Godbout, Roseline
    JOURNAL OF PATHOLOGY, 2019, 247 (02) : 186 - 198